GLP-1 receptor agonists: separating TikTok hype from clinical data

What did @jacklemay03 actually say?

This video is a clarification, not a claim. The creator is pushing back against what sounds like criticism or misreading of an earlier post. Their core message: being on GLP-1 medications does not mean you stop eating. "We enjoyed our Thanksgiving dinner. We were all able to eat a great amount of food and nourish our bodies." They also mention that their family works with dietitians and prioritizes protein and fiber. The video ends with a nudge to consult a provider before starting GLP-1 therapy.

Worth noting: the creator is speaking from personal and family experience, not as a medical professional. That framing matters when evaluating what they say.

Does the science back this up?

Yes, with some nuance. GLP-1 receptor agonists reduce appetite and slow gastric emptying, but they do not eliminate hunger or make eating impossible. Most clinical trial participants continue eating regular meals throughout treatment.

The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide reduced caloric intake, but participants were still consuming food and were counseled on diet throughout the study. The drug modulates appetite signaling, it does not shut it off. Similarly, the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) for tirzepatide showed meaningful weight loss alongside continued food consumption and lifestyle intervention. Neither trial described participants as unable to eat at social or holiday settings.

The creator's point that GLP-1 users can enjoy a normal Thanksgiving meal is consistent with how these medications actually work in practice.

What did they get wrong (or right)?

They got the core point right. GLP-1 medications reduce appetite, they do not cause people to stop eating entirely. The misconception they are correcting, that GLP-1 users cannot or do not eat, is genuinely common and genuinely wrong.

The recommendation to work with a dietitian is well-supported. Research from Batterham et al. (2021, Obesity Reviews) and others consistently shows that combining GLP-1 therapy with structured dietary guidance produces better outcomes than medication alone. Prioritizing protein and fiber is also clinically sound. Higher protein intake helps preserve lean muscle mass during weight loss, which is a real concern with GLP-1-driven caloric reduction (Bikou et al., 2023, Nutrients).

One thing to flag: "a great amount of food" is subjective. GLP-1 users do typically eat less than they would off medication, even if the meal feels satisfying. That is not a criticism of the creator, just a clarification that appetite reduction is part of how these drugs work.

What should you actually know?

GLP-1 medications change the relationship with food, they do not end it. Reduced appetite, smaller portions, and slower gastric emptying mean most users feel full faster and are less driven to overeat. But eating meals, including holiday meals, remains normal and expected.

The creator's advice to "speak to a provider" before starting is the right call. GLP-1 therapies are prescription medications with real side effect profiles, including nausea, vomiting, and in rare cases more serious gastrointestinal events. They are not appropriate for everyone, and dosing and monitoring should happen under clinical supervision.

Working with a registered dietitian during GLP-1 therapy is not just a nice-to-have. Muscle mass loss during rapid weight loss is a documented concern, and dietary guidance helps mitigate it. Anyone considering these medications should ask their provider about nutrition support as part of the overall plan.